Long et al. found that myeloid cell leukemia-1 protein (MCL-1) was significantly overexpressed in MCF-7/DOXR cells and that miR-193b sensitized breast cancer cells to doxorubicin by targeting MCL-1 [30]. Here, MCL1 is linked to breast cancer.